化疗端口皮肤侵蚀：我们的经验。
Chemoport-skin erosion: our experience.
作者信息
Harish K
机构信息
Department of Surgical Oncology, MS Ramaiah Curie Center of Oncology, MS Ramaiah Medical College, Bangalore, Karnataka, India.
出版信息
Int J Angiol. 2014 Sep;23(3):215-6. doi: 10.1055/s-0033-1353734.
Abstract
Chemoports are totally implantable venous access devices, which are retained over long periods of time to facilitate chemotherapy administration. Skin erosion is a rare complication wherein there is breach in the skin overlying the septum. This study reports the author's experience of skin erosion in three cases. Ports were explanted in all cases. Skin incision for port placement should be placed away from the access site and repeated access at the same point must be avoided to lessen the incidence of skin erosions.
摘要
化疗端口是完全植入式静脉通路装置，可长期留置以方便进行化疗给药。皮肤侵蚀是一种罕见的并发症，即覆盖隔膜的皮肤出现破损。本研究报告了作者对3例皮肤侵蚀病例的经验。所有病例均取出了端口。放置端口的皮肤切口应远离穿刺部位，并且必须避免在同一点反复穿刺，以降低皮肤侵蚀的发生率。
相似文献
1
Chemoport-skin erosion: our experience.化疗端口皮肤侵蚀：我们的经验。
Int J Angiol. 2014 Sep;23(3):215-6. doi: 10.1055/s-0033-1353734.
2
Totally Implantable Venous Access Devices in Children Requiring Long-Term Chemotherapy: Analysis of Outcome in 122 Children from a Single Institution.需要长期化疗的儿童完全植入式静脉通路装置：来自单一机构的122例儿童的结果分析
Indian J Surg Oncol. 2016 Sep;7(3):326-31. doi: 10.1007/s13193-015-0485-x. Epub 2016 Jan 13.
3
Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.用于长期化疗的完全植入式中心静脉通路导管。一项前瞻性研究，分析333个装置的并发症和成本，最短随访期为180天。
Ann Oncol. 1998 Jul;9(7):767-73. doi: 10.1023/a:1008392423469.
4
Totally Implantable Venous Access Device (Chemoport) in Oncology: Study of 168 Polyurethane Chemoport Catheter System.肿瘤学中完全植入式静脉通路装置（化疗端口）：168例聚氨酯化疗端口导管系统的研究
South Asian J Cancer. 2021 Dec 31;10(4):261-264. doi: 10.1055/s-0041-1739041. eCollection 2021 Dec.
5
Port-a-Cath fracture and migration in paediatric cancer patients: incidence and management at a tertiary care centre - a 15-year experience.儿童癌症患者的输液港骨折与移位：一家三级医疗中心的发病率及处理——15年经验
Cardiol Young. 2020 Jul;30(7):986-990. doi: 10.1017/S1047951120001390. Epub 2020 Jun 22.
6
Chemoport-A Savior in Children Who Require Chronic Venous Access: An Observational Study.Chemoport——需要长期静脉通路儿童的救星：一项观察性研究
Vasc Specialist Int. 2019 Sep;35(3):145-151. doi: 10.5758/vsi.2019.35.3.145. Epub 2019 Sep 30.
7
Chemoport Fracture due to Catheter Pinch Off Syndrome: A Rare Complication of Subclavian Vein Approach Revisited.导管夹闭综合征所致化学输液港骨折：锁骨下静脉置管罕见并发症再探讨
Indian J Surg Oncol. 2022 Jun;13(2):343-347. doi: 10.1007/s13193-021-01459-6. Epub 2021 Oct 9.
8
Complications of chemoport in children with cancer: Experience of 54,100 catheter days from a tertiary cancer center of Southern India.癌症患儿化疗端口的并发症：来自印度南部一家三级癌症中心54100导管日的经验。
South Asian J Cancer. 2015 Jul-Sep;4(3):143-5. doi: 10.4103/2278-330X.173179.
9
Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.用于实体瘤化疗的、连接到Groshong导管的长期完全植入式中心静脉通路端口：178例使用单一类型装置的经验
Eur J Cancer. 1997 Jul;33(8):1190-4. doi: 10.1016/s0959-8049(97)00039-7.
10
Clinical outcomes of totally implantable venous access port placement via the axillary vein in patients with head and neck malignancy.经腋静脉置入全植入式静脉通路港用于头颈部恶性肿瘤患者的临床结局
J Vasc Access. 2019 Mar;20(2):134-139. doi: 10.1177/1129729818781270. Epub 2018 Jun 20.
引用本文的文献
1
The correlation between subcutaneous fat thickness and the incidence of chemoport-related infection.皮下脂肪厚度与化疗端口相关感染发生率之间的相关性。
Infect Prev Pract. 2024 Dec 5;7(1):100433. doi: 10.1016/j.infpip.2024.100433. eCollection 2025 Mar.
2
Revisiting the Anatomical Landmark-Guided Central Venous Access Device Insertion: A Retrospective Cohort Study.重新审视解剖标志引导的中心静脉置管：一项回顾性队列研究。
World J Surg. 2023 Oct;47(10):2562-2567. doi: 10.1007/s00268-023-07088-0. Epub 2023 Jun 13.
3
Evaluation of complications of totally implantable central venous port system insertion.完全植入式中心静脉导管系统置入并发症的评估
Exp Ther Med. 2019 Mar;17(3):2013-2018. doi: 10.3892/etm.2019.7185. Epub 2019 Jan 18.
4
Implantable Port Devices, Complications and outcome in Pediatric Cancer, a Retrospective Study.植入式端口装置在儿童癌症中的并发症及结局：一项回顾性研究
Iran J Ped Hematol Oncol. 2016;6(1):1-8. Epub 2016 Mar 15.
本文引用的文献
1
Subcutaneous implantable venous access device erosion through the skin in patients treated with anti-vascular endothelial growth factor therapy: a case series.接受抗血管内皮生长因子治疗的患者皮下植入式静脉通路装置经皮侵蚀：病例系列
Anticancer Drugs. 2008 Feb;19(2):217-9. doi: 10.1097/CAD.0b013e3282f2c063.
2
Complications associated with the use of central venous access devices.与使用中心静脉通路装置相关的并发症。
Curr Probl Surg. 1996 Apr;33(4):309-78. doi: 10.1016/s0011-3840(96)80008-6.
3
Fifty-five patient years' experience with a totally implanted system for intravenous chemotherapy.关于完全植入式静脉化疗系统的55个患者年的经验。
Cancer. 1986 Mar 15;57(6):1124-9. doi: 10.1002/1097-0142(19860315)57:6<1124::aid-cncr2820570611>3.0.co;2-d.
4
Experience with subcutaneous infusion ports in three hundred patients.三百例患者皮下输注端口的使用经验。
Surg Gynecol Obstet. 1988 Apr;166(4):295-301.
Zotero 插件